✦ LIBER ✦

Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia

✍ Scribed by Hale, L. Paulette ;Smith, Karen ;Braden, Gregory A. ;Owen, John

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 143 KB
Volume: 45
Category: Article
ISSN: 0098-6569
DOI: 10.1002/(sici)1097-0304(199811)45:3<318::aid-ccd23>3.0.co;2-2

No coin nor oath required. For personal study only.

✦ Synopsis

Heparin is considered necessary during percutaneous coronary interventions; however, heparin is contraindicated in patients with heparin-induced thrombocytopenia and/or heparin antibodies. We describe the successful use of the heparinoid Orgaran (danaparoid sodium) in addition to abciximab (ReoPro) in a patient with heparin antibodies who required rotational atherectomy.

📜 SIMILAR VOLUMES

Characterization of the humoral immune r

Characterization of the humoral immune response in heparin-induced thrombocytopenia

✍ Suh, Jang-Soo; Malik, Mohammad I.; Aster, Richard H.; Visentin, Gian Paolo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

Recent reports indicate that antibodies associated with heparin-induced thrombocytopenia and thrombosis (HITP) are specific for complexes formed between heparin and the heparin-binding, platelet alpha granule protein, platelet factor 4 (PF4). As with other disorders mediated by immune complexes (IC)

Thrombocytopenia due to acute venous thr

Thrombocytopenia due to acute venous thromboembolism and its role in expanding the differential diagnosis of heparin-induced thrombocytopenia

✍ Craig S. Kitchens 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

Report of successful use of argatroban a

Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome

✍ Lewis, Bruce E. ;Iaffaldano, Robert ;McKiernan, Thomas L. ;Rao, Luxman ;Donkin, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) is a severe complication of heparin caused by an antibody response to the heparin-platelet factor 4 complex which results in severe thrombosis. Heparin rechallenge in HllTS patients carries a high risk of inducing thrombosis. Antithrom

Intracoronary adenosine administered dur

Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon

✍ George P. Hanna; Peter Yhip; Ken Fujise; George W. Schroth; Oscar R. Rosales; H. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

New laboratory test in flow cytometry fo

New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia

✍ Gobbi, Giuliana ;Mirandola, Prisco ;Tazzari, Pier Luigi ;Talarico, Enrica ;Caimi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

Use of plasma exchange in patients with

Use of plasma exchange in patients with heparin-induced thrombocytopenia: A report of two cases and a review of the literature

✍ Elizabeth A. Jaben; A. Sergio Torloni; Rajiv K. Pruthi; Jeffrey L. Winters 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract Heparin‐induced thrombocytopenia (HIT), which is characterized by thrombocytopenia and potentially serious thromboses, may develop in patients exposed to heparin anticoagulation. HIT is caused by antibodies to the heparin/platelet factor 4 (PF4) complex. Management of HIT involves disco